272 related articles for article (PubMed ID: 12712840)
1. [Bioavailability and its significance in pharmacotherapy].
Wiela-Hojeńska A; Orzechowska-Juzwenko K
Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840
[TBL] [Abstract][Full Text] [Related]
2. [Absorption and biological availability of drugs].
Uribe M
Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
[TBL] [Abstract][Full Text] [Related]
3. [Biologic availability and "1st pass" effect of drugs].
Rietbrock N; Keller F
Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
[TBL] [Abstract][Full Text] [Related]
4. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique.
von Richter O; Greiner B; Fromm MF; Fraser R; Omari T; Barclay ML; Dent J; Somogyi AA; Eichelbaum M
Clin Pharmacol Ther; 2001 Sep; 70(3):217-27. PubMed ID: 11557909
[TBL] [Abstract][Full Text] [Related]
5. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
Raaflaub J
Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
[TBL] [Abstract][Full Text] [Related]
6. An overview of the analysis and interpretation of bioavailability studies in man.
Wagner JG
Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a novel in vitro Caco-2 hepatocyte hybrid system for predicting in vivo oral bioavailability.
Lau YY; Chen YH; Liu TT; Li C; Cui X; White RE; Cheng KC
Drug Metab Dispos; 2004 Sep; 32(9):937-42. PubMed ID: 15319334
[TBL] [Abstract][Full Text] [Related]
8. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
9. [Drug dosing in chronic hepatic disease (author's transl)].
Gugler R; Eichelbaum M
Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
[TBL] [Abstract][Full Text] [Related]
10. First-pass elimination. Basic concepts and clinical consequences.
Pond SM; Tozer TN
Clin Pharmacokinet; 1984; 9(1):1-25. PubMed ID: 6362950
[TBL] [Abstract][Full Text] [Related]
11. [Biological availability].
Weber E; Gundert-Remy U
Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
[TBL] [Abstract][Full Text] [Related]
12. St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism.
Tannergren C; Engman H; Knutson L; Hedeland M; Bondesson U; Lennernäs H
Clin Pharmacol Ther; 2004 Apr; 75(4):298-309. PubMed ID: 15060508
[TBL] [Abstract][Full Text] [Related]
13. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
Lesne M
J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
[No Abstract] [Full Text] [Related]
14. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
15. The potential clinical significance of differences in bioavailability.
Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
[No Abstract] [Full Text] [Related]
16. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
Cabana BE
Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective first-pass metabolism of verapamil in the small intestine and liver in rats.
Hanada K; Ikemi Y; Kukita K; Mihara K; Ogata H
Drug Metab Dispos; 2008 Oct; 36(10):2037-42. PubMed ID: 18617604
[TBL] [Abstract][Full Text] [Related]
18. Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model.
Coelingh Bennink HJ; Heegaard AM; Visser M; Holinka CF; Christiansen C
Climacteric; 2008; 11 Suppl 1():2-14. PubMed ID: 18464016
[TBL] [Abstract][Full Text] [Related]
19. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
[TBL] [Abstract][Full Text] [Related]
20. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza, in rat.
Zhang Y; Akao T; Nakamura N; Duan CL; Hattori M; Yang XW; Liu JX
Planta Med; 2004 Feb; 70(2):138-42. PubMed ID: 14994191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
